Proposed draft message to board; I'll send on Monday to give everyone the weekend to suggest additions, alterations etc. Cheers
'Dear sirs,
This is on behalf of the shareholders who are also Hotcopper members.
We are aware of the companies efforts and big steps in the right direction.
However there are 3 fundamental factors of concern - disappointing sales; inability to get a deal with v2; lack of info from clinical trial, originally intended to be released earlier this year.
Given these issues we'd appreciate you:
- confirming for us the recent counting of approvals for options was done appropriately.
- and, bearing in mind a tendency to overstate in the past, reiterate when we can see even interim CT data.
Explanation of the rationale for packaging the burette and pericoach would also be welcome.
We look forward to your update.
Kind regards
...................
ALT Price at posting:
0.7¢ Sentiment: Hold Disclosure: Held
